
Prices hiked on 3,400 drugs in first half of 2019
pharmafile | July 4, 2019 | News story | Research and Development, Sales and Marketing | abstruse, access, generics, pharma, prescription, pricing
There have been price hikes on more than 3,400 drugs in the United States in the first six months of 2019, according to analysis by Rx Savings Solutions.
Prices increased by an average of 10.5%, a rate five times higher than the rate of inflation, the analysis says.
Around 41 drugs saw their prices double, increasing by more than 100%, including one version of the antidepressant Prozac (fluoxetine) the cost of which have increased by 879%
The number of price hikes has increased by 17% compared to the number of price hikes over the same period of time in 2018, during which period there were 2,900 price increases.
The price hikes have come in spite of pressure from the Trump administration on price hiking firms.
Meanwhile four out of five (79%) of Americans believe the drug prices are unreasonable, while three in ten said they had failed to take prescription medicines because costs were too high.
“In the political climate we live in and the conversations we’re having, that there are more drug price increases this year — you would think that wouldn’t be the case,” said Michael Rea, founder and CEO of Rx Savings Solutions. “It defines the difficulty that consumers have.”
Louis Goss
Related Content

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence
LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

Johnson & Johnson announces successful results from trial for myeloma treatment
Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed …

Bend Bioscience adds commercial spray drying facility to Georgia site
Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry …






